Table 2 Distribution of Pi*Mmalton (moderate and severe) and Pi*ZZ patients included in EARCO by Country
Patients in EARCO N = 2073 | Moderate PI*Mmalton N = 26 | Severe PI*Mmalton N = 33 | PI*ZZ N = 827 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
n | n | (% by Total) | (% by Country) | n | (% by Total) | (% by Country) | n | (% by Total) | (% by Country) | |
Argentina | 31 | - | - | - | - | - | - | 22 | (2.7%) | (71.0%) |
Austria | 8 | - | - | - | - | - | - | 7 | (0.8%) | (87.5%) |
Belgium | 54 | - | - | - | - | - | - | 14 | (1.7%) | (25.9%) |
Canada | 65 | - | - | - | - | - | - | 45 | (5.4%) | (69.2%) |
Colombia | 3 | - | - | - | - | - | - | 1 | (0.1%) | (33.3%) |
Croatia | 23 | - | - | - | - | - | - | 3 | (0.4%) | (13.0%) |
Czech republic | 58 | - | - | - | - | - | - | 54 | (6.5%) | (93.1%) |
Denmark | 48 | - | - | - | - | - | - | 48 | (5.8%) | (100.0%) |
Estonia | 8 | - | - | - | - | - | - | 8 | (1.0%) | (100.0%) |
France | 23 | - | - | - | - | - | - | 7 | (0.8%) | (30.4%) |
Germany | 68 | - | - | - | - | - | - | 42 | (5.1%) | (61.8%) |
Ireland | 9 | - | - | - | - | - | - | 2 | (0.2%) | (22.2%) |
Italy | 90 | 2 | (7.7%) | (2.2%) | 6 | (18.2%) | (6.6%) | 36 | (4.4%) | (40.0%) |
Netherlands | 37 | - | - | - | 1 | (3.0%) | (2.7%) | 22 | (2.7%) | (59.5%) |
Poland | 5 | - | - | - | - | - | - | 4 | (0.5%) | (80.0%) |
Portugal | 191 | 5 | (19.2%) | (2.6%) | 6 | (18.2%) | (3.1%) | 55 | (6.7%) | (28.8%) |
Romania | 3 | - | - | - | - | - | - | 3 | (0.4%) | (100.0%) |
Serbia and Montenegro | 2 | - | - | - | - | - | - | 1 | (0.1%) | (50.0%) |
Spain | 803 | 16 | (61.5%) | (2.0%) | 14 | (42.4%) | (1.7%) | 216 | (26.1%) | (26.9%) |
Sweden | 177 | - | - | - | - | - | - | 2 | (0.2%) | (1.1%) |
Switzerland | 68 | 3 | (11.5%) | (4.4%) | 1 | (3.0%) | (1.5%) | 24 | (2.9%) | (35.3%) |
Turkey | 5 | - | - | - | 1 | (3.0%) | (20.0%) | 4 | (0.5%) | (80.0%) |
United Kingdom | 294 | - | - | - | 3 | (9.1%) | (1.0%) | 207 | (25.0%) | (70.4%) |